<strong>Background:</strong><span style="font-family:;" "=""><span style="font-family:Verdana;"> Gabapentin is routinely prescribed preoperatively to decrease...<strong>Background:</strong><span style="font-family:;" "=""><span style="font-family:Verdana;"> Gabapentin is routinely prescribed preoperatively to decrease postoperative pain intensity. It is included in the enhanced recovery after surgery (ERAS) recommendations. </span><b><span style="font-family:Verdana;">Objective:</span></b><span style="font-family:Verdana;"> To analyze correlation of gabapentin dosage and post anesthesia care unit (PACU) length of stay (LOS) and cost. </span><b><span style="font-family:Verdana;">Study Design:</span></b><span style="font-family:Verdana;"> A retrospective chart review of patients who underwent general anesthesia and received preoperative oral gabapentin from June 2017 </span></span><span style="font-family:Verdana;">to</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> August 2017 for pelvic and breast procedures. The main outcome was correlation between PACU LOS and gabapentin dosage in the outpatients. Financial analysis was performed to assess the cost to the hospital associated with increased LOS. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> Of the 636 patients, 405 patients received 300 </span><span style="font-family:Verdana;">mg and 231 patients received 100 mg gabapentin. Mean dosage per kg (mg/k</span><span style="font-family:Verdana;">g ±</span></span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">SD) was 3.12</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">±</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">1.51 (range: </span><span style="font-family:Verdana;">0</span><span style="font-family:Verdana;">.86 to 6.12). PACU LOS was 96</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">±</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">77 (minutes ±</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">SD) in patients receiving 100 mg and 120</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">±</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">96 in patients receiving 300 mg capsule (p</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">=</span><span style="font-family:;" "=""> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">0.001). Linear regression analysis, failed to show a </span><span style="font-family:Verdana;">statistically significant correlation between per kg dosage and PACU LOS (</span><span style="font-family:Verdana;">p</span></span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> 0</span><span style="font-family:Verdana;">.13). Using multiple regression analysis, we calculated the correlation coefficient to be +1.71 minutes per 1mg/kg gabapentin (95% CI: -</span><span style="font-family:Verdana;">3.75 to +7.10, p</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> 0</span><span style="font-family:Verdana;">.54) after adjusting for confounders. Adding 3</span><span style="font-family:;" "=""> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">mg/kg to pre-op g</span><span style="font-family:Verdana;">abapentin dosage of all outpatients cost on average</span></span><span style="font-family:Verdana;">,</span><span style="font-family:Verdana;"> an extra $9794 per mo</span><span style="font-family:;" "=""><span style="font-family:Verdana;">nth in this cohort. </span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> Every 1mg/kg increase in gabapentin dosage adds an estimated 7.1 minutes to PACU LOS. A 3</span></span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">mg/kg increase in gabapentin adds estimated 22 additional minutes in PACU LOS. Unfortunately, increase LOS is associated with increased hospital costs.</span>展开更多
目的研究麻醉复苏室(Post-anesthesia care unit,PACU)护士对麻醉苏醒期风险认知和患者安全胜任力现状,并分析麻醉苏醒期风险认知和患者安全胜任力相关性的影响因素。方法采用分层多阶段聚类抽样法于2022年6月-8月抽取新疆16所综合性医...目的研究麻醉复苏室(Post-anesthesia care unit,PACU)护士对麻醉苏醒期风险认知和患者安全胜任力现状,并分析麻醉苏醒期风险认知和患者安全胜任力相关性的影响因素。方法采用分层多阶段聚类抽样法于2022年6月-8月抽取新疆16所综合性医院的228名PACU护士为研究对象,采用电子问卷形式,问卷由一般资料、麻醉苏醒期风险认知调查问卷和患者安全胜任力护士评价量表组成,收集PACU护士对麻醉苏醒期风险认知和患者安全胜任力情况,分析患者安全胜任力和麻醉苏醒期风险认知的相关性及影响因素。结果PACU护士麻醉苏醒期风险认知总得分为(97.34±8.06)分,患者安全胜任力护士评价量表总得分为(148.72±11.80)分。在不同医院级别、学历、职称、麻醉护理工作年限、麻醉风险应急预案和麻醉风险培训频率PACU护士的患者安全胜任力和麻醉苏醒期风险认知差异均有统计学意义(P<0.05)。Pearson相关性分析显示,PACU护士麻醉苏醒期风险认知与患者安全胜任力各维度呈正相关(P<0.05)。多元线性回归分析显示,麻醉护理工作年限、职称、麻醉风险培训频率、苏醒期风险认知总分是PACU护士患者安全胜任力的影响因素(P均<0.05)。结论PACU护士的麻醉苏醒期风险认知和患者安全胜任力处于中等偏上水平,麻醉苏醒期风险认知水平的改善有助于PACU护士提高患者安全胜任力。展开更多
目的回顾分析阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea and hypopnea syndrome,OSAHS)患者麻醉恢复室(post-anesthesia care unit,PACU)处理的临床资料,提高围术期安全性,降低并发症。方法分析我院东区PACU收治...目的回顾分析阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea and hypopnea syndrome,OSAHS)患者麻醉恢复室(post-anesthesia care unit,PACU)处理的临床资料,提高围术期安全性,降低并发症。方法分析我院东区PACU收治的96例OSAHS患者,对镇静镇痛方式、呼吸机治疗、监测手段进行总结。结果患者年龄26-62岁,体重70-112kg,呼吸暂停,低通气指数(AHI)≥40,合并高血压37例、糖尿病12例,心电图检查示ST段或T波改变22例,左心室高电压17例,完全性右束支传导阻滞9例。所有患者术后均保留经鼻气管插管PACU过夜,1例患者拔管后再插管入ICU治疗,其余患者术后第2天晨拔管返回病房,均未发生术后知晓、气管切开、术后出血。结论重症OSAHS患者术后给予合理镇静镇痛留置气管导管过夜是安全和快速恢复的理想方式。展开更多
文摘<strong>Background:</strong><span style="font-family:;" "=""><span style="font-family:Verdana;"> Gabapentin is routinely prescribed preoperatively to decrease postoperative pain intensity. It is included in the enhanced recovery after surgery (ERAS) recommendations. </span><b><span style="font-family:Verdana;">Objective:</span></b><span style="font-family:Verdana;"> To analyze correlation of gabapentin dosage and post anesthesia care unit (PACU) length of stay (LOS) and cost. </span><b><span style="font-family:Verdana;">Study Design:</span></b><span style="font-family:Verdana;"> A retrospective chart review of patients who underwent general anesthesia and received preoperative oral gabapentin from June 2017 </span></span><span style="font-family:Verdana;">to</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> August 2017 for pelvic and breast procedures. The main outcome was correlation between PACU LOS and gabapentin dosage in the outpatients. Financial analysis was performed to assess the cost to the hospital associated with increased LOS. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> Of the 636 patients, 405 patients received 300 </span><span style="font-family:Verdana;">mg and 231 patients received 100 mg gabapentin. Mean dosage per kg (mg/k</span><span style="font-family:Verdana;">g ±</span></span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">SD) was 3.12</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">±</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">1.51 (range: </span><span style="font-family:Verdana;">0</span><span style="font-family:Verdana;">.86 to 6.12). PACU LOS was 96</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">±</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">77 (minutes ±</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">SD) in patients receiving 100 mg and 120</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">±</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">96 in patients receiving 300 mg capsule (p</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">=</span><span style="font-family:;" "=""> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">0.001). Linear regression analysis, failed to show a </span><span style="font-family:Verdana;">statistically significant correlation between per kg dosage and PACU LOS (</span><span style="font-family:Verdana;">p</span></span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> 0</span><span style="font-family:Verdana;">.13). Using multiple regression analysis, we calculated the correlation coefficient to be +1.71 minutes per 1mg/kg gabapentin (95% CI: -</span><span style="font-family:Verdana;">3.75 to +7.10, p</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> 0</span><span style="font-family:Verdana;">.54) after adjusting for confounders. Adding 3</span><span style="font-family:;" "=""> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">mg/kg to pre-op g</span><span style="font-family:Verdana;">abapentin dosage of all outpatients cost on average</span></span><span style="font-family:Verdana;">,</span><span style="font-family:Verdana;"> an extra $9794 per mo</span><span style="font-family:;" "=""><span style="font-family:Verdana;">nth in this cohort. </span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> Every 1mg/kg increase in gabapentin dosage adds an estimated 7.1 minutes to PACU LOS. A 3</span></span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">mg/kg increase in gabapentin adds estimated 22 additional minutes in PACU LOS. Unfortunately, increase LOS is associated with increased hospital costs.</span>
文摘目的研究麻醉复苏室(Post-anesthesia care unit,PACU)护士对麻醉苏醒期风险认知和患者安全胜任力现状,并分析麻醉苏醒期风险认知和患者安全胜任力相关性的影响因素。方法采用分层多阶段聚类抽样法于2022年6月-8月抽取新疆16所综合性医院的228名PACU护士为研究对象,采用电子问卷形式,问卷由一般资料、麻醉苏醒期风险认知调查问卷和患者安全胜任力护士评价量表组成,收集PACU护士对麻醉苏醒期风险认知和患者安全胜任力情况,分析患者安全胜任力和麻醉苏醒期风险认知的相关性及影响因素。结果PACU护士麻醉苏醒期风险认知总得分为(97.34±8.06)分,患者安全胜任力护士评价量表总得分为(148.72±11.80)分。在不同医院级别、学历、职称、麻醉护理工作年限、麻醉风险应急预案和麻醉风险培训频率PACU护士的患者安全胜任力和麻醉苏醒期风险认知差异均有统计学意义(P<0.05)。Pearson相关性分析显示,PACU护士麻醉苏醒期风险认知与患者安全胜任力各维度呈正相关(P<0.05)。多元线性回归分析显示,麻醉护理工作年限、职称、麻醉风险培训频率、苏醒期风险认知总分是PACU护士患者安全胜任力的影响因素(P均<0.05)。结论PACU护士的麻醉苏醒期风险认知和患者安全胜任力处于中等偏上水平,麻醉苏醒期风险认知水平的改善有助于PACU护士提高患者安全胜任力。
文摘目的回顾分析阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea and hypopnea syndrome,OSAHS)患者麻醉恢复室(post-anesthesia care unit,PACU)处理的临床资料,提高围术期安全性,降低并发症。方法分析我院东区PACU收治的96例OSAHS患者,对镇静镇痛方式、呼吸机治疗、监测手段进行总结。结果患者年龄26-62岁,体重70-112kg,呼吸暂停,低通气指数(AHI)≥40,合并高血压37例、糖尿病12例,心电图检查示ST段或T波改变22例,左心室高电压17例,完全性右束支传导阻滞9例。所有患者术后均保留经鼻气管插管PACU过夜,1例患者拔管后再插管入ICU治疗,其余患者术后第2天晨拔管返回病房,均未发生术后知晓、气管切开、术后出血。结论重症OSAHS患者术后给予合理镇静镇痛留置气管导管过夜是安全和快速恢复的理想方式。